Skip Navigation

Long Term Follow-Up of Patients Exposed to Lentiviral-Based CD19 Directed CAR T-Cell Therapy

Brief Summary

Type:
Lymphomas

Study Type:
Other

Phase:
N/A

ClinicalTrials.gov Identifier:
NCT02445222

Study #:
CMH - CCTL019A2205B

Start Date:
Jul 28, 2015

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02445222

View Complete Trial Details & Eligibility at ClinicalTrials.gov